July 20-25, 2008
Gordon Research Conference, NICHD; NIH Office of Rare Diseases; National Cancer Institute; National Institute of Environmental Health Sciences; United Kingdom Environmental Mutagenesis Society; the Genetics Society; Ozgene; Glen Research; New England Biolabs; Sigma-Aldrich; Roche; Trilink Biotechnologies; ProteinOne; Oxford Journals; Enzymax; Novus Biologicals; Genscript; and Trevigen
Magdelen College, Oxford, United Kingdom
The conference will focus on the molecular mechanisms of mutagenesis that give rise to genomic instability. The goals of this meeting are to identify new avenues of investigation, to define therapeutic strategies for maintenance of genomic integrity, to stimulate collaborations, and to foster the long-term development of this critical research area.
Dr. Roger Woodgate, Chief, Laboratory of Genomic Integrity, Division of Intramural Research, NICHDTel: (301) 217-4040Fax: (301) 217-5815E-mail: firstname.lastname@example.orgE-mail: email@example.com